March 6, 2025 - 03:00

A recent study has highlighted potential mental health risks linked to gender-affirming surgeries. Researchers found that transgender individuals who underwent these procedures reported increased levels of depression, anxiety, and suicidal ideation two years post-surgery.
The findings suggest that while gender-affirming surgeries can be crucial for many in aligning their physical appearance with their gender identity, they may also be associated with adverse mental health outcomes. This underscores the importance of comprehensive mental health support before and after surgical procedures.
Experts emphasize that the transition process can be complex and multifaceted, often accompanied by societal pressures and stigmas that may exacerbate mental health issues. The study calls for increased awareness and resources to address these challenges, ensuring that individuals receive the necessary psychological support throughout their transition journey.
As discussions around transgender healthcare continue to evolve, understanding the full spectrum of impacts—both positive and negative—remains essential for fostering well-being in the transgender community.
July 23, 2026 - 15:06
Good riddance to bundled ‘global’ maternal care billingThe American College of Obstetricians and Gynecologists is welcoming a major shift in how pregnancy and childbirth are billed. For years, the system relied on a single, bundled `global` fee that...
July 22, 2026 - 21:50
West Nile virus found in two mosquito traps in DeKalb County, health officials sayHealth authorities in DeKalb County have confirmed that mosquitoes collected from two separate traps have tested positive for the West Nile virus. The positive samples were identified during...
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...